Disclosures for "Closing the Care Divide in Rett Syndrome: Connecting Centers of Excellence With Community Clinicians Through a Multidisciplinary, Multiphase, Geotargeted Educational Initiative "
-
Ms. Gupta has nothing to disclose.
-
Carole Drexel has nothing to disclose.
-
Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene.
-
Dr. Bartolotta has received personal compensation in the range of $0-$499 for serving as a Consumer Reviewer with General Dynamics. Dr. Bartolotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with International Rett Syndrome Foundation.
-
Dr. Hasson has nothing to disclose.
-
The institution of Dr. Armstrong has received research support from Taysha.
-
Dr. Keough has nothing to disclose.
-
Dr. Ananth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Therapeutics. The institution of Dr. Ananth has received research support from Acadia Pharmaceuticals.